Ex Parte Finch et al - Page 5



                    Appeal 2006-3191                                                                                                       
                    Application 10/397,765                                                                                                 

                            For the foregoing reasons, as well as those stated in the Brief and                                            
                    Reply Brief, we determine that the Examiner has failed to establish a prima                                            
                    facie case of obviousness in view of Durden.  We note that Muller was only                                             
                    applied by the Examiner to show the well-known anilide pesticides of claims                                            
                    2-4 and 15 (Answer 5).  Therefore, Muller does not remedy the deficiencies                                             
                    in the rejection as discussed above.  Accordingly, we cannot sustain either                                            
                    rejection on appeal.                                                                                                   
                            The decision of the Examiner is reversed.                                                                      
                                                             REVERSED                                                                      

                                                                                                                                          










                    clj                                                                                                                    
                    Novak, Druce, Deluca & Quigg, LLP                                                                                      
                    1300 Eye Street, N.W.                                                                                                  
                    Suite 400 East Tower                                                                                                   
                    Washington, DC  20005                                                                                                  

                                                                    5                                                                      




Page:  Previous  1  2  3  4  5

Last modified: November 3, 2007